We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Scoring Angioplasty Platform Dilates Calcified Vessels

By HospiMedica International staff writers
Posted on 15 Jun 2020
A novel metal-alloy sheath platform converts angioplasty balloons into atherosclerotic plaque scoring and cutting systems. More...


The Transit Scientific (Park City, UT, USA) XO Score percutaneous transluminal angioplasty (PTA) scoring sheath platform is intended for use in iliac, ilio-femoral, popliteal, infra-popliteal, and renal arterial vessels, as well as in synthetic and/or native arteriovenous hemodialysis fistulas. For use, clinicians first insert an off-the-shelf PTA balloon into the XO Score at the tableside, following which the system can be used over-the-wire to dilate calcified plaque and prepare vessels. The low-profile, flexible, metal-alloy exoskeleton comes with a balloon expandable scoring section.

The XO Score has up to 22 scoring/cutting struts that lay flat while tracking, but rotate by 90° during balloon inflation to score and cut 0.25mm, 0.35mm, or 0.50mm (0.020") slits, deep enough to enable precise dilation across a range of lesion types. The struts rotate 90° back during deflation. The XO Score is available in 6.3Fr diameter and 65cm or 125cm working lengths, and can be used with a number of 4-8mm diameter and 20-40mm long PTA balloons. Future 3Fr, 4Fr, and 5Fr over-the-wire and rapid-exchange XO Score versions are under development for smaller vessel and coronary use.

“XO Score transforms regular PTA balloons into scoring and cutting systems. It adds new technology and value to angioplasty. Rotating struts allow clinicians to vary scoring depth without increasing device profile,” said Greg Method, President of Transit Scientific. “Economically, XO Score offers a direct value proposition; One XO Score and an off-the-shelf PTA balloon will cost less than one specialty PTA scoring or cutting technology.”

PTA is usually performed with expandable polymer balloon catheters in order to dilate atherosclerotic narrowed blood vessels. Calcified, fibrous, and/or resilient stenosis may require special scoring or cutting angioplasty balloons with integrated wires or blades on the balloon. While such features improve the dilating force, they result in large crossing profiles and limit deliverability, while at the same time increasing cost and inventory.

Related Links:
Transit Scientific


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.